MARÍA JOSÉ
HERRERO CERVERA
AYUDANTE DOCTOR/A
Federico
Moscardó García
Publicaciones en las que colabora con Federico Moscardó García (7)
2018
-
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Pharmacogenomics Journal, Vol. 18, Núm. 2, pp. 301-307
2017
-
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Leukemia and Lymphoma, Vol. 58, Núm. 5, pp. 1197-1206
-
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia
Pharmacogenetics and Genomics, Vol. 27, Núm. 7, pp. 270-274
-
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Leukemia and Lymphoma, Vol. 58, Núm. 12, pp. 2880-2894
2016
-
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
Pharmacogenomics Journal, Vol. 16, Núm. 1, pp. 30-40
-
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: A systematic review and meta-analysis
Pharmacogenomics Journal
2015
-
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Pharmacogenomics Journal, Vol. 15, Núm. 2, pp. 109-118